Search research articles
Contact Us
Filters
Showing results (41-50 of 100) with videos related to
Page
of 10
Sort By:
Life Science Alliance
|
March 8, 2024
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis
Melissa R Perrino, Niousha Ahmari, Ashley Hall, et al.
Cancers
|
May 13, 2023
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study
Chelsea Kotch, Kristina Wagner, J Harris Broad, et al.
Pediatric Blood & Cancer
|
September 11, 2019
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS)
Julia W Cohen, Brigitte C Widemann, Joanne Derdak, et al.
Pediatric Research
|
August 28, 2024
Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment
Kathryn M Lemberg, Andrea M Gross, Lauren M Sproule, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents
Maya Lodish, Urania Dagalakis, Clara C Chen, et al.
Acta Neuropathologica
|
October 27, 2012
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
Carlos E Prada, Edwin Jousma, Tilat A Rizvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma
Elizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.
Neuro-Oncology
|
August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas
Regina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
Pediatric Blood & Cancer
|
September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
AeRang Kim, Eva Dombi, Kathleen Tepas, et al.
Journal of Neuro-Oncology
|
February 19, 2024
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 100) with videos related to
Sort By:
Page
of 10
Life Science Alliance
|
March 8, 2024
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis
Melissa R Perrino, Niousha Ahmari, Ashley Hall, et al.
Cancers
|
May 13, 2023
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study
Chelsea Kotch, Kristina Wagner, J Harris Broad, et al.
Pediatric Blood & Cancer
|
September 11, 2019
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS)
Julia W Cohen, Brigitte C Widemann, Joanne Derdak, et al.
Pediatric Research
|
August 28, 2024
Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment
Kathryn M Lemberg, Andrea M Gross, Lauren M Sproule, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents
Maya Lodish, Urania Dagalakis, Clara C Chen, et al.
Acta Neuropathologica
|
October 27, 2012
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
Carlos E Prada, Edwin Jousma, Tilat A Rizvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma
Elizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.
Neuro-Oncology
|
August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas
Regina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
Pediatric Blood & Cancer
|
September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
AeRang Kim, Eva Dombi, Kathleen Tepas, et al.
Journal of Neuro-Oncology
|
February 19, 2024
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, et al.
Page
of 10